DAYANARA GOHIL: Open Payments
NPI 1821319252 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 36 payments from 7 companies in 2025. Trend: 2023 $276 · 2024 $799 · 2025 $1,083
Food & beverage: $1,012Education: $71
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 6 | $362 |
| ABBVIE INC. | 11 | $261 |
| Teva Pharmaceuticals USA, Inc. | 6 | $184 |
| Alkermes, Inc. | 6 | $127 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Janssen Scientific Affairs, LLC | 1 | $29 |
Products named: VRAYLAR, INGREZZA, ARISTADA, UZEDY, CAPLYTA, TRINTELLIX, AUSTEDO XR, INVEGA SUSTENNA.
Industry payments across CO — which companies pay providers there.
